Nuvation Bio Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
All right, well, good afternoon, everybody, and thank you once again for joining us for our seventh annual Oncology Innovation Summit. I'm Yaron Werber from the TD Cowan Biotech team. And as the Excel survey is now launched, if you do feel that the TD Cowen biotech team has earned your support, please do consider voting for us for both large-cap and small and mid-cap. It's a great pleasure to moderate the next session with Innovation Bio.
Really, we have two gentlemen that need no introduction. We have David Hong, founder, President, and CEO, and Philippe Sauvage, who is the Chief Financial Officer. So, Tim, thanks for joining us. Good to see you.
Thanks for having us here.
Questions & Answers
So lots to talk about.
I'd be TROSI, both commercially and then potentially to start even talking about other tumors that have ROS1 mutations. But
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
